Back to Agenda
Session 8: Quality Assurance in Drug Development (GxPs)
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Good Clinical Practices
- Institutional Review Boards
- Informed Consent
- Good Laboratory Practices
- Good Manufacturing Practices
Have an account?